Literature DB >> 2188160

Oral complications of cancer therapies. Management of mucositis during therapy.

C Miaskowski1.   

Abstract

This paper reviews the purposes of an oral care protocol, the major components of an oral care regimen, and oral care protocols and studies done to date. Many questions remain in the area of optimal oral care for the patient experiencing mucositis as a sequela of cancer treatment. Research is needed on types and use of mouth rinses, effective, harmless, and pleasant lip lubricants, appropriate analgesic and anti-inflammatory combinations, and the effectiveness of a variety of devices for oral cleansing, to name a few areas. As outpatient oncology services grow, oral care protocols must be developed to meet the needs of ambulatory patient populations. Oral care regimens must be safe, easy to use, and economical as well as effective to ensure patient and staff compliance. Research on the management of mucositis must be conducted in both inpatient and outpatient settings. Finally, in order to obtain sufficient sample sizes and optimize data collection, these studies will need to be conducted by multidisciplinary teams (including dentists, oncologists, radiation therapists, and nurses) across multiple sites. Not until large-scale clinical trials are done on the treatment of mucositis will we be able to optimize the therapeutic regimen for the patient.

Entities:  

Mesh:

Year:  1990        PMID: 2188160

Source DB:  PubMed          Journal:  NCI Monogr        ISSN: 0893-2751


  3 in total

Review 1.  Palliative dental care- a boon for debilitating.

Authors:  Bhavana Sujana Mulk; Raja Lakshmi Chintamaneni; Prabhat Mpv; Sarat Gummadapu; Shyam Sundar Salvadhi
Journal:  J Clin Diagn Res       Date:  2014-06-20

2.  Association of tumor necrosis factor-α polymorphism with chemotherapy-induced oral mucositis in patients with esophageal cancer.

Authors:  Kazuhiko Sakamoto; Shigeru Takeda; Shinsuke Kanekiyo; Mitsuo Nishiyama; Masahiro Kitahara; Tomio Ueno; Shigeru Yamamoto; Shigefumi Yoshino; Shoichi Hazama; Naoko Okayama; Hiroaki Nagano
Journal:  Mol Clin Oncol       Date:  2016-11-14

3.  Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy--a randomized controlled trial.

Authors:  Anncarin Svanberg; Gunnar Birgegård; Kerstin Ohrn
Journal:  Support Care Cancer       Date:  2007-03-29       Impact factor: 3.603

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.